HIV InfectionsHIV SeropositivityHIV SeroprevalenceHIV SeronegativityHIV-1AIDS SerodiagnosisHIV AntigensAnti-HIV AgentsAcquired Immunodeficiency SyndromeHIV Protease InhibitorsSexual BehaviorHomosexuality, MaleRisk-TakingCD4 Lymphocyte CountAnti-Retroviral AgentsHIV Core Protein p24South AfricaHIV Reverse TranscriptaseViral LoadHIV Envelope Protein gp120Receptors, HIVHIV ProteaseSexual PartnersSubstance Abuse, IntravenousPrevalenceTreatment OutcomeHIV Long-Term SurvivorsCondomsAIDS-Related Opportunistic InfectionsHealth Knowledge, Attitudes, PracticeUnsafe SexUgandaZimbabweRisk FactorsCoinfectionCounselingCross-Sectional StudiesDrug Therapy, CombinationHIV EnteropathyProstitutionVoluntary ProgramsHIV Envelope Protein gp41Safe SexCD4-Positive T-LymphocytesAfrica South of the SaharaMalawiAIDS Dementia ComplexUnited StatesTime FactorsSyphilisEpidemicsZambiaHeterosexualityCohort StudiesVirus ReplicationCircumcision, MaleMass ScreeningIndiaRNA, ViralTuberculosisHIV Fusion InhibitorsHIV Wasting SyndromePatient Acceptance of Health CareHIV Integrase InhibitorsSocial StigmaStereotypingPregnancyAntiprotozoal AgentsHepatitis CSex WorkersHIV-2Antitubercular AgentsIncidenceRetrospective StudiesTanzaniaProspective StudiesQuestionnairesHIV SerosortingInterviews as TopicKenyaHomosexualityFollow-Up StudiesDrug Resistance, ViralRural PopulationThailandSocioeconomic FactorsRisk Reduction BehaviorTuberculosis, PulmonarySubstance-Related DisordersDrug UsersPopulation SurveillanceAnti-Bacterial AgentsHIV IntegrasePrisonersZidovudineTruth DisclosureDeveloping CountriesPatient ComplianceBisexualityEthiopia